Stock ZENI.P ZENITH CAPITAL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Zenith Capital Corporation

Equities

ZENI.P

CA98936P1071

Biotechnology & Medical Research

Market Closed - Toronto S.E.
Other stock markets
 11:00:00 2024-04-16 EDT 		5-day change 1st Jan Change
0.105 CAD -.--% Intraday chart for Zenith Capital Corporation -.--% -.--%
03-28 Zenith Capital Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024 CI
2023 Zenith Capital Corporation Reports Earnings Results for the Full Year Ended July 31, 2023 CI

Valuation

Fiscal Period: July 2020 2021 2022 2023
Capitalization 1 0.45 0.35 0.3627 0.4426
Enterprise Value (EV) 1 0.2282 0.1401 0.2902 0.3631
P/E ratio -2.67 x -7.31 x -2.45 x -2.33 x
Yield - - - -
Capitalization / Revenue - - - -
EV / Revenue - - - -
EV / EBITDA - - - -
EV / FCF 102,034,884 x -8,063,820 x -3,686,971 x -3,387,941 x
FCF Yield 0% -0% -0% -0%
Price to Book 2.04 x 1.68 x 5.03 x 5.38 x
Nbr of stocks (in thousands) 2,500 2,500 2,590 4,215
Reference price 2 0.1800 0.1400 0.1400 0.1050
Announcement Date 10/15/20 11/8/21 11/16/22 11/27/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: July 2019 2020 2021 2022 2023
Net sales - - - - -
EBITDA - - - - -
EBIT 1 -0.2526 -0.0744 -0.0288 -0.1234 -0.1664
Operating Margin - - - - -
Earnings before Tax (EBT) 1 -0.265 -0.0878 -0.0426 -0.1449 -0.1897
Net income 1 -0.265 -0.0878 -0.0426 -0.1449 -0.1897
Net margin - - - - -
EPS - -0.0674 -0.0192 -0.0571 -0.0450
Free Cash Flow - 0.002236 -0.0174 -0.0787 -0.1072
FCF margin - - - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 10/25/19 10/15/20 11/8/21 11/16/22 11/27/23
1CAD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: July 2019 2020 2021 2022 2023
Net Debt 1 - - - - -
Net Cash position 1 0.12 0.22 0.21 0.07 0.08
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - 0 -0.02 -0.08 -0.11
ROE (net income / shareholders' equity) - -48.8% -19.9% -104% -246%
ROA (Net income/ Total Assets) - -25.6% -8.29% -53.5% -127%
Assets 1 - 0.3436 0.5139 0.2711 0.1496
Book Value Per Share 2 0.2800 0.0900 0.0800 0.0300 0.0200
Cash Flow per Share 2 0.2500 0.0900 0.0800 0.0300 0.0200
Capex - - - - -
Capex / Sales - - - - -
Announcement Date 10/25/19 10/15/20 11/8/21 11/16/22 11/27/23
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
ZENITH CAPITAL CORPORATION Stock Zenith Capital Corporation
-.--% 325K
MODERNA, INC. Stock Moderna, Inc.
+33.37% 49.46B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.55% 42.58B
LONZA GROUP AG Stock Lonza Group AG
+49.11% 42.49B
CELLTRION, INC. Stock Celltrion, Inc.
-4.22% 29.09B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.57% 26.61B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.00% 18.64B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+7.36% 13.16B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+28.30% 12.55B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+23.80% 12.1B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. ZENI.P Stock
  4. Financials Zenith Capital Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW